Dyne Therapeutics, Inc. (DYN)
NASDAQ · Healthcare
$23.45-1.22%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $3.87B
- P/E ratio
- —
- EPS
- —
- Volume
- 2,528,626
- 52-week high
- —
- 52-week low
- —
- Open
- $24.56
- Day high
- $24.79
- Day low
- $23.37
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$446.21M | -$3.47 |
| 2024 | — | -$317.42M | -$3.37 |
| 2023 | — | -$235.94M | -$3.95 |
| 2022 | — | -$168.1M | -$3.23 |
| 2021 | — | -$149.29M | -$2.93 |
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
- CEO
- John G. Cox
- Employees
- 258
- Country
- US
- IPO date
- Sep 17, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Dyne Therapeutics, Inc.'s stock price today?
- DYN is trading at $23.45 as of Jul 20, 2026.
- What is Dyne Therapeutics, Inc.'s market cap?
- Dyne Therapeutics, Inc. (DYN) has a market capitalization of $3.87B.
- Does Dyne Therapeutics, Inc. pay a dividend?
- Dyne Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Dyne Therapeutics, Inc. in?
- Dyne Therapeutics, Inc. operates in the Healthcare sector.